PubVisualPubVisual Book a Demo
Resources Blog About Contact Book a 30-Minute Demo →

Payer Engagement in Pharma: Beyond the Dossier

Payers don’t need a longer dossier, they need one they can navigate to their own question.

The short version
  • A value dossier is built to be comprehensive. A payer analyst with a specific question has to read through material built for every question to find hers.
  • A payer conversation is rarely about volume of evidence. An interactive value story lets her go straight to her question, then the next one.
  • Nothing about the underlying evidence changes. What changes is the structure, a value story she can move through by her own question.

Payers don’t need a longer dossier, they need one they can navigate to their own question. Here's what we found, and what it means for how you build your next story.

01The dossier does its job, and stops there

A value dossier is built to be comprehensive. A payer analyst with a specific question has to read through material built for every question to find the answer to hers.

Same finding, two shapesStatic page
The publication as published
The same finding, designed
One finding

Payer Engagement in Pharma: Beyond the Dossier, told as a story a physician can finish.

The physician readerstill scanning the table…
0:38time to the point
Fig. 01The same approved finding, shown as a static page and as a designed story.

02What a payer actually wants in the room

A payer conversation is rarely about volume of evidence. An interactive value story lets her go straight to her question, then the next one, without paging backward through sections she doesn’t need yet.

“A payer analyst with a specific question has to read through material built for every question to find the answer to hers.”

03Same evidence, structured to be found

Nothing about the underlying evidence changes. What changes is the structure, a value story built so a payer can move between the clinical case, the economic case, and the real-world case depending on her question.

04Beyond the submission moment

A dossier gets built once and often ages badly. A visual value story built the same way stays useful past that first moment, because it was built to answer questions, not to document a single point in time.

The Impact Gap ReportFree · request access
Request the report →
Written by
The PubVisual Team
Editorial · PubVisual

We build the science communication our own field teams would want to use, then hand it to yours. This post came out of that same process.

More from the blog →
The Science of Engagement

Let her steer, from the same approved core

PubVisual Engage gives payers a value story built around their questions, not a document built around yours.

Questions

Frequently asked questions

No. The dossier keeps doing its job of being comprehensive. The interactive value story is a way through the same evidence, structured so a payer can go straight to her question instead of reading material built for every question.

The payer moves between the clinical case, the economic case, and the real-world case depending on her question, without paging backward through sections she doesn't need yet.

That's the idea. A dossier gets built once and often ages badly. A value story built to answer questions keeps working past that first moment.